Cancer-associated fibroblasts: from basic science to anticancer therapy
D Yang, J Liu, H Qian, Q Zhuang - Experimental & Molecular Medicine, 2023 - nature.com
Abstract Cancer-associated fibroblasts (CAFs), as a central component of the tumor
microenvironment in primary and metastatic tumors, profoundly influence the behavior of …
microenvironment in primary and metastatic tumors, profoundly influence the behavior of …
Glucose metabolism of TAMs in tumor chemoresistance and metastasis
J Liu, X Cao - Trends in Cell Biology, 2023 - cell.com
Tumor-associated macrophages (TAMs) are critical in promoting tumor progression and
therapeutic resistance. In adapting to metabolic changes in the tumor microenvironment …
therapeutic resistance. In adapting to metabolic changes in the tumor microenvironment …
Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer
RD Cervantes-Villagrana, I García-Jiménez… - Cellular …, 2023 - Elsevier
Metastatic cancer cells dynamically adjust their shape to adhere, invade, migrate, and
expand to generate secondary tumors. Inherent to these processes is the constant assembly …
expand to generate secondary tumors. Inherent to these processes is the constant assembly …
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Breast cancer, the most frequent female malignancy, is often curable when detected at an
early stage. The treatment of metastatic breast cancer is more challenging and may be …
early stage. The treatment of metastatic breast cancer is more challenging and may be …
Antibody drug conjugates in breast cancer in China: Highlights, challenges, and prospects
J Li, Z Jiang - Cancer, 2024 - Wiley Online Library
Antibody drug conjugates (ADCs) are novel drugs that exert specific cytotoxicity against
tumor cells. China approved T‐Dxd in May 2023, and their introduction has changed the …
tumor cells. China approved T‐Dxd in May 2023, and their introduction has changed the …
Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers
X Wu, S Huang, W He, M Song - International Immunopharmacology, 2023 - Elsevier
HER2 is an established therapeutic target in breast, gastric, and gastroesophageal junction
carcinomas with HER2 overexpression or genomic alterations. The humanized monoclonal …
carcinomas with HER2 overexpression or genomic alterations. The humanized monoclonal …
Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy …
J Zhu, Q Huang, X Peng, C Luo, Z Liu, D Liu… - Frontiers in …, 2023 - frontiersin.org
Background Previous studies have demonstrated that PANoptosis is strongly correlated with
cancer immunity and progression. This study aimed to develop a PANoptosis-related …
cancer immunity and progression. This study aimed to develop a PANoptosis-related …
A TGF-β–dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children
X Xiang, Y Hao, C Cheng, H Hu, H Chen, J Tan… - Hepatology, 2024 - journals.lww.com
A TGF-β–dominant chemoresistant phenotype of hepatoblastoma... : Hepatology A TGF-β–dominant
chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children …
chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children …
Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy
G Cui, S Deng, B Zhang, M Wang, Z Lin… - Advanced …, 2024 - Wiley Online Library
The extracellular matrix (ECM) is critical for drug resistance in colorectal cancer (CRC). The
abundant collagen within the ECM significantly influences tumor progression and matrix …
abundant collagen within the ECM significantly influences tumor progression and matrix …
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and …
S Nersesian, RJ Arseneau, JP Mejia, SN Lee… - Frontiers in …, 2024 - frontiersin.org
Background For patients with high grade serous carcinoma of the ovary (HGSC), survival
rates have remained static for the last half century. Despite the presence of tumor mutations …
rates have remained static for the last half century. Despite the presence of tumor mutations …